Declan Doogan is of Biohaven Pharmaceutical Holding Co Ltd.. Currently has a direct ownership of 870,648 shares of BHVN, which is worth approximately $31.5 Million. The most recent transaction as insider was on Nov 29, 2021, when has been sold 24,525 shares (Common Shares) at a price of $112.83 per share, resulting in proceeds of $2,767,156. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 871K
0% 3M change
0% 12M change
Total Value Held $31.5 Million

Declan Doogan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 29 2021
SELL
Open market or private sale
$2,767,156 $112.83 p/Share
24,525 Reduced 2.74%
870,648 Common Shares
Nov 16 2021
SELL
Open market or private sale
$4,408,787 $116.82 p/Share
37,740 Reduced 4.05%
895,173 Common Shares
Nov 16 2021
BUY
Exercise of conversion of derivative security
$13,091,780 $23.42 p/Share
559,000 Added 37.47%
932,913 Common Shares

Also insider at

TENX
TENAX THERAPEUTICS, INC. Healthcare
DD

Declan Doogan

Morrisville, NC

Track Institutional and Insider Activities on BHVN

Follow Biohaven Pharmaceutical Holding Co Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BHVN shares.

Notify only if

Insider Trading

Get notified when an Biohaven Pharmaceutical Holding CO Ltd. insider buys or sells BHVN shares.

Notify only if

News

Receive news related to Biohaven Pharmaceutical Holding Co Ltd.

Track Activities on BHVN